Bull
$5.06
Scenario price
$4.140
+0.020 (+0.49%)At close
James River Group Holdings, Inc. is a holding company. The Company owns and operates a group of insurance companies with the objective of generating compelling returns on tangible equity while limiting underwriting and investment volatility. It operates in three segments: Excess and Surplus Lines, Specialty Admitted Insurance, and Corporate and Other segments. The Excess and Surplus Lines segment offers commercial excess and surplus lines liability and excess property insurance in every U.S. state, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business. The Corporate and Other segment consists of the management, technology, treasury activities, and interest expense. Its insurance companies include James River Group Holdings UK Limited, James River Group, James River Insurance Company, and Falls Lake National Insurance Company.
James River Group Holdings Ltd (JRVR) is currently not a strong buy due to its recent performance and analyst downgrades. The stock is priced at $4.14, which is significantly below its 52-week high of $7.20, indicating a potential for value but also substantial risk. The RSI is at 46.3, suggesting it is neither overbought nor oversold, which reflects a lack of strong momentum. Furthermore, the forward P/E ratio is 6.01, indicating the stock is undervalued relative to earnings, but the company has faced challenges with net income fluctuations, including a recent net income of $4.4 million, which is a 59% increase from the previous quarter but still reflects volatility. The main risk is highlighted by the downgrade from UBS, citing increased competition and a higher equity cost of capital, which could hinder growth prospects. Therefore, while there are some positive indicators, the overall outlook suggests a cautious approach rather than a definitive buy.
UBS
$8
2026-05-19
UBS
2026-05-19
Price Target
$8
Citizens
—
2026-05-05
Citizens
2026-05-05
Price Target
—
Compass Point
$7
2025-12-16
Compass Point
2025-12-16
Price Target
$7
Keefe, Bruyette & Woods
$5
2025-03-13
Keefe, Bruyette & Woods
2025-03-13
Price Target
$5
Truist Securities
$5
2025-03-11
Truist Securities
2025-03-11
Price Target
$5
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

James River Group Reports Q2 Highlights with Strategic Focus on E&S Segment

James River Group Shares Rise 3% as Shareholder Activism Increases

James River Group Stock Shows Oversold Signal

James River Group Holdings Q1 2026 Earnings Call Insights

James River Group Stock Downgraded Following Q1 Earnings Miss
James River Group Holdings, Inc. is a holding company. The Company owns and operates a group of insurance companies with the objective of generating compelling returns on tangible equity while limiting underwriting and investment volatility. It operates in three segments: Excess and Surplus Lines, Specialty Admitted Insurance, and Corporate and Other segments. The Excess and Surplus Lines segment offers commercial excess and surplus lines liability and excess property insurance in every U.S. state, the District of Columbia, Puerto Rico and the U.S. Virgin Islands. The Specialty Admitted Insurance segment focuses on niche classes within the standard insurance markets with a primary focus on fronting business. The Corporate and Other segment consists of the management, technology, treasury activities, and interest expense. Its insurance companies include James River Group Holdings UK Limited, James River Group, James River Insurance Company, and Falls Lake National Insurance Company. It operates in the Financials sector (FIRE, MARINE & CASUALTY INSURANCE industry).
James River Group Holdings Ltd (JRVR) is currently not a strong buy due to its recent performance and analyst downgrades. The stock is priced at $4.14, which is significantly below its 52-week high of $7.20, indicating a potential for value but also substantial risk. The RSI is at 46.3, suggesting it is neither overbought nor oversold, which reflects a lack of strong momentum. Furthermore, the forward P/E ratio is 6.01, indicating the stock is undervalued relative to earnings, but the company has faced challenges with net income fluctuations, including a recent net income of $4.4 million, which is a 59% increase from the previous quarter but still reflects volatility. The main risk is highlighted by the downgrade from UBS, citing increased competition and a higher equity cost of capital, which could hinder growth prospects. Therefore, while there are some positive indicators, the overall outlook suggests a cautious approach rather than a definitive buy.
6 analysts cover JRVR: 3 rate it Buy, 3 Hold and 0 Sell. The average price target is 7.00.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.